dpp 4 inhibitors and glp 1 DPP4 vs GLP-1 Agonists | June 2021 | Clinical Corner The pharmacology of DPP-4 inhibitors
Description
Inflammatory markers like C-reactive protein decrease
Multiple drugs targeting GLP-1 functions, ER UPR, bile acid signaling, and the microbiota have already proven to be effective in the treatment of T2D and IBD (Figure 6)
Neuronal lesioning with axonally transported toxins
Should a question arise, we can easily walk over to the nurses desk to for clarification if necessary
